Deng et al. showed that IGF2BP2 can bind to mRNA in an m6A-dependent manner and thus has the potential to become a new diagnostic and therapeutic target for patients with Alzheimer's disease (52). The gene discussed is IGF2BP2; the disease is Alzheimer disease.